News Mount Sinai Health System and IBM Research Launch Effort That Leverages Artificial Intelligence and Behavioral Data to Improve Mental Health Care for Young People
News SGLT2 Inhibitor Empagliflozin Is Shown to Be Safe and Effective for Treating Patients Who Have Suffered a Heart Attack
News Connecting the Human Brain to Artificial Intelligence: What Early Clinical Experience at Mount Sinai Is Revealing about Brain-Computer Interfaces
News Mount Sinai Creates Headache Registry to Study the Heterogeneity of Migraine and Develop Precision Medicine Treatment Approaches